Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
Teixeira AM, Garrido P, Santos P, Alves R, Parada B, Costa E, Almeida A, Teixeira-Lemos E, Sereno J, Pinto R, Belo L, Santos-Silva A, Teixeira F, Reis F.
Teixeira AM, et al. Among authors: alves r.
Ren Fail. 2010;32(9):1073-80. doi: 10.3109/0886022X.2010.509897.
Ren Fail. 2010.
PMID: 20863212
Free article.